Paytient

Paytient is a financial services company focused on the healthcare sector. It provides a Health Payment Account (HPA), which is an interest-free, fee-free line of credit for medical, dental, vision, pharmacy, behavioral health, and veterinary care expenses. This financial product is designed not as a loan or a traditional ‘Buy Now Pay Later’ option but as a sponsored benefit that works alongside high deductible health plans, health savings accounts, flexible spending accounts, health reimbursement arrangements, and other health benefits, making it easier for users to manage their healthcare expenses over time​​​​.

In May 2024, Paytient appointed Joe Gabler as its chief growth officer (CGO). The company noted Gabler's role in the company would be vital to expanding Paytient's strategic partnerships with leading employers, payers, and pharmacy benefit managers (PBMs) and driving the overall growth of the company.

Key customers and partnerships

Paytient offers its HPA platform to a broad range of partners, including employers, payers (such as insurance companies), and health systems. As of January 2023, Paytient worked with about 700 corporate partners across the US, serving 700,000 individuals on their platform.

As of February 2024, the company had collaborated with recognized health benefits providers such as Cigna, Centene Corporation, MetLife, Delta Dental, and Maven.​ These collaborations enable Paytient's integration with existing health benefits, offering its users a complementary solution to manage their healthcare expenses more effectively.

In September 2024, Paytient partnered with HealthEquity, an HSA custodian, to provide Health Payment Accounts (HPAs) for employees. The partnership aimed to improve access to essential care by eliminating credit checks and reducing employee financial stress. The collaboration was expected to benefit employees—by providing greater confidence in pursuing healthcare—and employers—by potentially lowering high-cost claims through better access to preventive care.